Tim Watkins
CMO & Head of Development · 3 filings · Latest: Jun 30, 2026
Contineum Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CTNM | Tim Watkins | CMO & Head of Development | Jun 30, 2026 | Sale | $16.02 | 10,833 | $173.6K | 8,961 | |
CTNM | Tim Watkins | CMO & Head of Development | Jun 30, 2026 | Option Exercise | $4.50 | 10,833 | $48.7K | 19,794 | |
CTNM | TIMOTHY WATKINS | — | Jun 30, 2026 | Proposed Sale | $15.00 | 10,833 | $162.5K | — | |
CTNM | Tim Watkins | CMO & Head of Development | Mar 2, 2026 | Sale | $15.02 | 3,611 | $54.2K | 0 | |
CTNM | Tim Watkins | CMO & Head of Development | Mar 2, 2026 | Option Exercise | $4.50 | 3,611 | $16.2K | 3,611 | |
CTNM | Tim Watkins | CMO & Head of Development | Jan 28, 2026 | Sale | $14.18 | 3,611 | $51.2K | 0 | |
CTNM | Tim Watkins | CMO & Head of Development | Jan 28, 2026 | Option Exercise | $4.50 | 3,611 | $16.2K | 3,611 | |
CTNM | TIMOTHY WATKINS | — | Dec 29, 2025 | Proposed Sale | $12.41 | 10,833 | $134.4K | — |